Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > 06996 ANTENGENE-B > Detailed Quotes

06996 ANTENGENE-B

3.490
+0.300+9.40%
Closed 10/05 16:08 CCT
High
3.510
Open
3.210
Turnover
1.52M
Low
3.210
Pre Close
3.190
Volume
446.50K
Market Cap
2.32B
P/E(TTM)
Loss
52wk High
13.060
Shares
664.38M
P/E(Static)
Loss
52wk Low
3.050
Float Cap
2.32B
Bid/Ask %
15.60%
Historical High
22.500
Shs Float
664.38M
Volume Ratio
0.34
Historical Low
3.050
Dividend TTM
--
Div Yield TTM
--
P/B
0.90
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.07%
Amplitude
9.40%
Avg Price
3.410
Lot Size
500
Float Cap
2.32B
Bid/Ask %
15.60%
Historical High
22.500
Shs Float
664.38M
Volume Ratio
0.34
Historical Low
3.050
Dividend TTM
--
P/B
0.90
Dividend LFY
--
Turnover Ratio
0.07%
Amplitude
9.40%
Avg Price
3.410
Lot Size
500
Price Forecast

No Data

News

Comment

Company Overview More
Deqi Pharmaceutical Co., Ltd. is a clinical stage biopharmaceutical company in the Asia-Pacific region focusing on the innovation of antineoplastic drugs. The company is mainly engaged in the discovery, development, production and commercialization of biotechnology products. The company's key products include ATG-010 (selinexor) for the treatment of recurrent / refractory multiple myeloma, recurrent / refractory diffuse large B-cell B-cell lymphoma and non-small cell lung cancer, and ATG-008 (onatasertib) for a variety of indications, including hepatocellular carcinoma and non-small cell lung cancer. The company mainly operates in the Asia-Pacific region.
CEO: Jianming Mei
Market: Hong Kong motherboard
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...